Synthesis and Docking Studies of Glycolipids Inspired by Bacteroides fragilis Lipid A
Molecules · 2025
DOI: 10.3390/molecules30193927 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Davie Kenneth und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Università degli Studi di Milano, Via C. Golgi 19, 20133 Milan, Italy. Hauptthemen laut MEDLINE: Bacteroides fragilis, Molecular Docking Simulation, Lipid A, Glycolipids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU NextGenerationEU-MUR PNRR Extended Partnership, Marie Curie Sklodowska-Curie European Training Network (ETN) GLYCOVAX, Next Generation EU "Missione 4 - Componente 1" GLYCONANOVACS.
Abstract (Originalsprache)
Bacteroides fragilis, a prominent commensal of the human gut microbiota, plays a vital role in immune system regulation through its capsular polysaccharide A (PSA), which requires a glycolipid anchor structurally reminiscent of lipid A. While canonical Escherichia coli lipid A acts as a potent TLR4 agonist contributing to septic shock and inflammatory disorders, certain B. fragilis-derived glycolipids demonstrate antagonistic effects, offering potential as anti-inflammatory agents. In this study, we report the synthesis and preliminary computational evaluation of a library of glycolipids inspired by B. fragilis lipid A. Three lipid As, including a tetra-acylated 1-phosphoryl lipid A analog (Tetra C-1), were synthesized and assessed using molecular docking simulations targeting the human TLR4/MD-2 complex. Docking results reveal that Tetra C-1 exhibits more favorable antagonist binding characteristics compared to the well-studied TLR4 antagonist Eritoran. This work highlights a microbiota-informed strategy for the development of novel TLR4 antagonists, potentially enabling targeted modulation of innate immunity for therapeutic applications in inflammatory diseases and as vaccine adjuvants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Università degli Studi di Milano, Via C. Golgi 19, 20133 Milan, Italy.
- Laboratory for Polymers and Biomaterials, Fondazione Istituto Italiano di Tecnologia, 16163 Genova, Italy.
ORCID-Profile: Cristina Manuela Santi, Francesca Tanda, Monica Civera, Giuseppe D'Orazio, Luigi Lay
Förderung
- EU NextGenerationEU-MUR PNRR Extended Partnership
- Marie Curie Sklodowska-Curie European Training Network (ETN) GLYCOVAX
- Next Generation EU "Missione 4 - Componente 1" GLYCONANOVACS
- University of Milan Research Grant PSR2025
- EU funding within the NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
- European Union’s Horizon 2020 research and innovation programme
- Next Generation EU “Missione 4—Componente 1-CUP
Zitieren
APA
Kenneth, D., Santi, C. M., Tanda, F., Izzo, A., Civera, M., D'Orazio, G., & Lay, L. (2025). Synthesis and Docking Studies of Glycolipids Inspired by Bacteroides fragilis Lipid A. Molecules. https://doi.org/10.3390/molecules30193927
Vancouver
Kenneth D, Santi CM, Tanda F, Izzo A, Civera M, D'Orazio G, et al. Synthesis and Docking Studies of Glycolipids Inspired by Bacteroides fragilis Lipid A. Molecules. 2025. doi:10.3390/molecules30193927
BibTeX
@article{Kenneth2025,
author = {Kenneth, Davie and Santi, Cristina Manuela and Tanda, Francesca and Izzo, Alessia and Civera, Monica and D'Orazio, Giuseppe and Lay, Luigi},
title = {Synthesis and Docking Studies of Glycolipids Inspired by Bacteroides fragilis Lipid A},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30193927}
}
EUVIMED